Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Mr Jonathan Evans
+44 (0)117 455 1591
camelot-trial@bristol.ac.uk


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - CAMELOT - Continuous rectus sheath Analgesia in eMErgency LaparOTomy

CAMELOT - Continuous rectus sheath Analgesia in eMErgency LaparOTomy

Medical Conditions

Use of rectus sheath catheters (RSCs) in patients undergoing emergency bowel surgery.


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


In the UK around 30,000 patients, a year undergo an operation called an emergency laparotomy to treat life-threatening conditions. A large vertical cut is made in the abdomen when patients are asleep under general anesthesia. Good pain relief after surgery will help patients feel better and recover quicker. Because of the high level of pain experienced by many patients, opioid-based painkillers such as morphine are often given, using patient-controlled analgesia (PCA) pumps. However, morphine can cause serious side effects such as breathing problems, nausea and vomiting, and delayed bowel movement, which can slow patient recovery. Rectus sheath catheters (RSCs) are a newer way of providing pain relief, where two thin tubes (catheters) are inserted on either side of the wound during the operation. Local anesthetic is injected slowly into the catheters to numb the nerves and reduce pain for about three days. Small studies suggest that RSCs may provide effective pain relief, reduce the use of morphine, and help patient recovery. Potential disadvantages are that RSCs take time to insert and are expensive. More work is needed to understand whether there are any unwanted effects with RSCs.

This study will find out whether adding a RSCs to standard patient-controlled analgesia provides better pain relief, fewer side effects and complications, and greater satisfaction for patients undergoing emergency laparotomy compared to a control group who will receive a sham catheter with no infusion of analgesia. Our study will also aim to determine whether RSCs are safe and cost-effective.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

25 Jan 2023 01 Sep 2025

Participants will be allocated to one of two groups, with an equal chance of being in either group (like tossing a coin). An active Rectus Sheath Catheter (RSC) with a constant infusion of local anesthesia for 72 h from the end of surgery will be given to one group of participants. The other group will receive a sham rectus sheath catheter with an inactive infusion device in place for 72 h from the end of surgery. Participants and researchers will not have a choice in which of the two treatments will be given to each participant and will not know which treatment participants have received during the study.


Adults who are due to undergo emergency laparotomy surgery.

You can take part if:



You may not be able to take part if:


Current participant exclusion criteria:1. Planned epidural anaesthesia 2. Clinician refusal3. Lack of mental capacity to consent to trial participation4. Contraindications to RSC including allergy to local anaesthetic (LA), anatomical factors making RSC insertion impossible5. Existing co-enrolment in another clinical study if:5.1. The intervention in the other study is expected to influence the primary outcome (this will be considered by a senior clinician on a case-by-case basis)5.2. It is considered too burdensome for the patient; or5.3. It is not permitted by the other study6. Previous enrolment in the CAMELOT trial



Previous participant exclusion criteria:1. Clinician or patient refusal to participate2. Planned epidural anaesthesia3. Contraindications to Rectus Sheath Catheter (RSC) including allergy to local anaesthetic (LA)4. Anatomical factors making RSC insertion impossible


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • North Bristol NHS Trust
    Southmead Hospital Southmead Road Westbury-on-trym
    Bristol
    BS10 5NB
  • University Hospitals Birmingham NHS Foundation Trust
    Queen Elizabeth Hospital Mindelsohn Way Edgbaston
    Birmingham
    B15 2GW
  • NHS Greater Glasgow and Clyde
    J B Russell House Gartnavel Royal Hospital 1055 Great Western Road Glasgow
    Glasgow
    G12 0XH
  • Leeds Teaching Hospitals NHS Trust
    St. James's University Hospital Beckett Street
    Leeds
    LS9 7TF
  • Manchester University NHS Foundation Trust
    Cobbett House Oxford Road
    Manchester
    M13 9WL
  • Croydon University Hospital
    London Road
    Croydon
    CR7 7YE
  • Royal Derby Hospital
    Uttoxeter Road
    Derby
    DE22 3NE
  • Barts Health NHS Trust
    The Royal London Hospital 80 Newark Street
    London
    E1 2ES
  • The Royal Wolverhampton NHS Trust
    New Cross Hospital Wolverhampton Road Heath Town
    Wolverhampton
    WV10 0QP
  • Great Western Hospitals NHS Foundation Trust
    Great Western Hospital Marlborough Road
    Swindon
    SN3 6BB
  • Musgrove Park Hospital
    Musgrove Park
    Taunton
    TA1 5DA
  • The Dudley Group NHS Foundation Trust
    Russells Hall Hospital Pensnett Road
    Dudley
    DY1 2HQ
  • Royal Liverpool University Hospital NHS Trust
    Royal Liverpool University Hospital Prescot Street
    Liverpool
    L7 8XP
  • Blackpool Teaching Hospitals NHS Foundation Trust
    Victoria Hospital Whinney Heys Road
    Blackpool
    FY3 8NR
  • Heartlands Hospital
    Bordesley Green East Bordesley Green
    Birmingham
    B9 5ST
  • South Tees Hospitals NHS Trust
    Middlesbrough General Hospital Ayresome Green Lane
    Middlesbrough
    TS5 5AZ
  • Royal Alexandra Hospital
    Corsebar Road
    Paisley
    PA2 9PN
  • Ayrshire Central Hospital
    Kilwinning Road
    Irvine
    KA12 8SS
  • Medway NHS Foundation Trust
    Medway Maritime Hospital Windmill Road
    Gillingham
    ME7 5NY
  • City Hospitals Sunderland NHS Foundation Trust
    Sunderland Royal Hospital Kayll Road
    Sunderland
    SR4 7TP
  • York Hospitals NHS Trust Hq
    York Hospital Wigginton Road
    York
    YO31 8HE

The benefits of the CAMELOT study are that we hope that patients will have less pain after their operation and that their recovery/discharge time may be quicker.
1. Disconnection. Occasionally the RSCs may become accidentally disconnected from the pump. If this happens, we will remove the RSCs to prevent infection, and you will be able to have other forms of pain relief.
2. Infection. This will be actively monitored by the participant’s clinician who will treat accordingly and remove the RSC.
3. Bleeding. This will be actively monitored by the participant’s clinician who will treat accordingly and remove the RSC.


The study is sponsored by University Hospital Southampton NHS Foundation Trust and funded by National Institute for Health and Care Research; Health Technology Assessment Programme.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: ISRCTN15475290

Or CPMS 53589

Last updated 04 September 2023

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.